Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM

5
2
Favorite

Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM

Dow Jones2022-08-03

By Chris Wack

Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System.

The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes.

This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes.

Through its affiliated companies, Anthem, now Elevance Health Inc., serves people across 14 states, including more than 45 million within its family of health plans.

The stock hit its 52-week low of 77 cents on May 12.

Write to Chris Wack at chris.wack@wsj.com

$(END)$ Dow Jones Newswires

August 03, 2022 10:30 ET (14:30 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（2）

AddyYamada
·2022-08-04
Time to release the tigers
Reply
Like
Report
yngwin111
·2022-08-04
Good news
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2256962689?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-03 22:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2256962689","market":"hk","top_or_hot":-1,"title":"Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System. \n</p>\n<p>\n  The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes. \n</p>\n<p>\n  This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes. \n</p>\n<p>\n  Through its affiliated companies, Anthem, now <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> Inc., serves people across 14 states, including more than 45 million within its family of health plans. \n</p>\n<p>\n  The stock hit its 52-week low of 77 cents on May 12. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 03, 2022 10:30 ET (14:30 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSenseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-03 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Chris Wack \n\n\n \n\n\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose ...</p>\n\n<a href=\"http://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2256962689","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2256962689","pubTimestamp":1659537000,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"By Chris Wack \n\n\n \n\n\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the comp","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","SENS":"Senseonics Holdings,Inc.","ELV":"Elevance Health"},"translate_title":"在Anthem提供植入式CGM覆盖后，Senseonics股价上涨19%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SENS":1,"ELV":0.9},"content_text":"By Chris Wack \n\n\n \n\n\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System. \n\n\n  The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes. \n\n\n  This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes. \n\n\n  Through its affiliated companies, Anthem, now Elevance Health Inc., serves people across 14 states, including more than 45 million within its family of health plans. \n\n\n  The stock hit its 52-week low of 77 cents on May 12. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  August 03, 2022 10:30 ET (14:30 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9906588789,"gmtCreate":1659570869143,"gmtModify":1705981667833,"author":{"id":"3581501387896968","authorId":"3581501387896968","name":"AddyYamada","avatar":"https://static.tigerbbs.com/402d7a21f36220356cdb5b666eefdf1d","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Time to release the tigers","listText":"Time to release the tigers","text":"Time to release the tigers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9906588789","repostId":2256962689,"repostType":2,"repost":{"id":"2256962689","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1659537000,"share":"https://www.laohu8.com/m/news/2256962689?lang=&edition=full","pubTime":"2022-08-03 22:30","market":"hk","language":"en","title":"Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2256962689","media":"Dow Jones","summary":"By Chris Wack \n\n\n \n\n\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the comp","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System. \n</p>\n<p>\n  The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes. \n</p>\n<p>\n  This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes. \n</p>\n<p>\n  Through its affiliated companies, Anthem, now <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> Inc., serves people across 14 states, including more than 45 million within its family of health plans. \n</p>\n<p>\n  The stock hit its 52-week low of 77 cents on May 12. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 03, 2022 10:30 ET (14:30 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSenseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-08-03 22:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System. \n</p>\n<p>\n  The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes. \n</p>\n<p>\n  This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes. \n</p>\n<p>\n  Through its affiliated companies, Anthem, now <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> Inc., serves people across 14 states, including more than 45 million within its family of health plans. \n</p>\n<p>\n  The stock hit its 52-week low of 77 cents on May 12. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 03, 2022 10:30 ET (14:30 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ELV":"Elevance Health","SENS":"Senseonics Holdings,Inc.","BK4082":"医疗保健设备"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2256962689","content_text":"By Chris Wack \n\n\n \n\n\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System. \n\n\n  The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes. \n\n\n  This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes. \n\n\n  Through its affiliated companies, Anthem, now Elevance Health Inc., serves people across 14 states, including more than 45 million within its family of health plans. \n\n\n  The stock hit its 52-week low of 77 cents on May 12. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  August 03, 2022 10:30 ET (14:30 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9906291044,"gmtCreate":1659546038391,"gmtModify":1705981452306,"author":{"id":"3565225896317833","authorId":"3565225896317833","name":"yngwin111","avatar":"https://static.tigerbbs.com/7b6da8ffb6e7348c5800f5edb3ff9e62","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Good news&nbsp;","listText":"Good news&nbsp;","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9906291044","repostId":2256962689,"repostType":2,"repost":{"id":"2256962689","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1659537000,"share":"https://www.laohu8.com/m/news/2256962689?lang=&edition=full","pubTime":"2022-08-03 22:30","market":"hk","language":"en","title":"Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2256962689","media":"Dow Jones","summary":"By Chris Wack \n\n\n \n\n\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the comp","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System. \n</p>\n<p>\n  The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes. \n</p>\n<p>\n  This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes. \n</p>\n<p>\n  Through its affiliated companies, Anthem, now <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> Inc., serves people across 14 states, including more than 45 million within its family of health plans. \n</p>\n<p>\n  The stock hit its 52-week low of 77 cents on May 12. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 03, 2022 10:30 ET (14:30 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSenseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-08-03 22:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System. \n</p>\n<p>\n  The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes. \n</p>\n<p>\n  This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes. \n</p>\n<p>\n  Through its affiliated companies, Anthem, now <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> Inc., serves people across 14 states, including more than 45 million within its family of health plans. \n</p>\n<p>\n  The stock hit its 52-week low of 77 cents on May 12. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 03, 2022 10:30 ET (14:30 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ELV":"Elevance Health","SENS":"Senseonics Holdings,Inc.","BK4082":"医疗保健设备"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2256962689","content_text":"By Chris Wack \n\n\n \n\n\n  Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System. \n\n\n  The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes. \n\n\n  This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes. \n\n\n  Through its affiliated companies, Anthem, now Elevance Health Inc., serves people across 14 states, including more than 45 million within its family of health plans. \n\n\n  The stock hit its 52-week low of 77 cents on May 12. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  August 03, 2022 10:30 ET (14:30 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":5,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}